Table 1. Prevalence rates with 95% confidence intervals for anti-filarial antibodies based on the Brugia Rapid test in children aged between 3 and 10 years of age prior to MDA (2001) and after one or more rounds of MDA.
Year | N examined | % Brugia Rapid Positive | 95% CI |
2001 | 120 | 82.0 | 75.1–88.8 |
2003 | 243 | 39.1 | 32.9–45.2 |
2004 | 202 | 41.1 | 34.3–47.9 |
2005 | 164 | 22.6 | 16.2–29.0 |
2006 | 138 | 13.0 | 7.4–18.6 |
2007 | 119 | 6.7 | 2.2–11.2 |
2008 | 115 | 13.9 | 7.4–20.2 |
2009 | 103 | 3.9 | 0.2–7.6 |
2010 | 116 | 4.9 | 0.6–8.0 |
The last round of MDA was performed in 2007. Since only selective treatment of MF carriers was performed in 2001, no Brugia Rapid tests were performed on the samples collected in 2002.